What did @freedomintheslowlane actually say?
One week into tirzepatide (Mounjaro) at the starting dose of 2.5mg, the creator reported losing 13.6 pounds. She acknowledged this is "not necessarily ideal" but framed it as a motivating kickstart. She also noted nausea right after her first injection, fatigue she partially attributed to poor sleep, and persistent constipation she said she "should have paid a little bit more attention to." She described dietary changes including a caloric deficit, cutting sugar, and stopping alcohol entirely.
To her credit, she flagged the constipation explicitly, avoided dramatizing the weight number, and didn't claim tirzepatide alone caused the loss. That self-awareness matters when we're talking about a video with 17,000+ views on a platform full of people who may be starting the same medication.
Does the science back this up?
Rapid early weight loss on GLP-1 medications is documented, but 13.6 pounds in seven days almost certainly includes significant water weight and glycogen depletion, not just fat. Research supports this reading.
The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed tirzepatide produced average weight loss of 20.9% of body weight over 72 weeks at the highest dose, but that's across a year and a half, not a week. Week-one data in clinical trials typically shows 1-3 pounds of loss, though people with more weight to lose, those cutting alcohol, and those in a significant caloric deficit can see larger early drops. A 2021 review by Wilding et al. in NEJM on semaglutide noted that early rapid loss is largely water and stored glycogen, particularly when carbohydrate intake drops sharply. Her cutting alcohol and sugar simultaneously would accelerate this effect considerably.
The side effects she described, including nausea and constipation, are among the most commonly reported in tirzepatide trials. In SURMOUNT-1, constipation affected roughly 17% of participants at the 5mg dose, with onset often in the first weeks.
What did she get wrong (or right)?
She got the side effect profile right. Nausea, fatigue, and constipation are textbook week-one tirzepatide experiences, and she reported them honestly without minimizing or catastrophizing. That's more than a lot of these videos do.
Where the framing gets shaky is the 13.6-pound figure. It's real on the scale, but presenting it as "week one progress" without explaining that a large portion is likely water weight could set unrealistic expectations for other viewers. Someone watching who loses 3 pounds in week one might conclude the medication isn't working for them, when in reality they may be losing more actual fat.
She also didn't mention hydration, which is relevant: GLP-1 medications can reduce thirst alongside appetite, and constipation combined with reduced fluid intake is a real risk in early weeks. That's a gap worth noting, not a catastrophic error, but an important one.
She correctly avoided attributing all the loss to the medication and acknowledged her own dietary changes. That intellectual honesty is worth crediting.
What should you actually know?
If you're starting tirzepatide or any GLP-1 medication and see dramatic week-one scale movement, don't build your expectations around it. A review by Hall and Kahan (2018, Medical Clinics of North America) on obesity pharmacotherapy confirmed that early rapid loss is largely fluid-related, and the rate reliably slows as the body adjusts. The long-term data is strong for tirzepatide specifically, but it works over months, not days.
On constipation: this is a genuinely underreported issue in GLP-1 content. Tirzepatide slows gastric motility as part of how it works. Increasing fiber, staying well hydrated, and talking to a clinician before reaching for laxatives is the appropriate approach. Tea and unspecified "pills" is not a protocol anyone prescribed.
- Nausea and constipation in week one are expected and well-documented in clinical trials.
- Large early weight loss on GLP-1 medications typically reflects water and glycogen loss, not fat alone.
- Stopping alcohol and cutting sugar simultaneously can produce rapid scale drops independent of the medication.
- Constipation risk is real; hydration is part of managing it, not optional.
- Week-one results are not predictive of long-term progress on tirzepatide.